Analysis of Pathogenic Bacteria Distribution and Related Factors in Recurrent Acute Cholangitis
Kaili Li,Xiaoxue Hu,Quanyi Lu,Heng Zhang,Jiayi Zhou,Shijing Tian,Fachun Zhou
DOI: https://doi.org/10.2147/IDR.S418752
2023-07-21
Infection and Drug Resistance
Abstract:Kaili Li, Xiaoxue Hu, Quanyi Lu, Heng Zhang, Jiayi Zhou, Shijing Tian, Fachun Zhou Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China Correspondence: Shijing Tian; Fachun Zhou, Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical, University, 1 Youyi Road, Yuzhong Qu, 3rd Floor, Building 1, Chongqing, People's Republic of China, Tel +23-89011756, Email ; Background: To evaluate the risk factors and prognosis of patients with acute cholangitis recurrence. Methods: A total of 503 patients with acute cholangitis admitted to the First Affiliated Hospital of Chongqing Medical University between July 2013 and January 2022 were included in this retrospective observational study, who were followed up for 360 days and divided into relapse group and non-recurrence group according to the recurrence of acute cholangitis. Risk factors and prognosis of patients with acute cholangitis recurrence were analyzed by univariate, multivariate analyses and proportional hazards model. Results: A total of 161 patients with recurrent acute cholangitis were identified. Recurrent acute cholangitis usually occurred within 125 days; Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, and Enterococcus faecium was the most common positive record both in blood and bile culture. In the multivariate analysis, abdominal pain (OR = 2.448, 95% CI = 1.196– 5.010, P = 0.014), bile stones (OR = 2.429, 95% CI = 1.024– 5.762, P = 0.044), diabetes (OR = 1.790, 95% CI = 1.007– 3.182, P = 0.047), pathogen (OR = 3.305, 95% CI = 1.932– 5.654, P < 0.001), and chronic kidney disease (OR = 2.500, 95% CI = 1.197– 5.221, P = 0.015) may be ascertained as the risk factors of acute cholangitis recurrence. The recurrence of acute cholangitis was identified as an independent risk factor for patient death (HR = 4.524, 95% CI = 1.426– 14.357, P = 0.010) by Cox proportional-hazards regression. Conclusion: Abdominal pain, bile stones, diabetes and chronic kidney disease may be risk factors of acute cholangitis recurrence. Patients with recurrent acute cholangitis have poor prognosis and high mortality. Early control of recurrent risk factors and active intervention are beneficial to high-risk patients. Keywords: recurrence, acute cholangitis, risk factors, prognosis Acute cholangitis is a clinical syndrome characterized by fever, jaundice, and abdominal pain, with symptoms ranging from mild recurrent illness to severe sepsis. 1 Patients die of cholangitis due to delayed diagnosis, systemic disease, or failure to respond to conservative treatment, which poses a huge challenge to clinical resource consumption. 2 In recent years, with the further understanding of the pathogenesis and pathophysiological evolution of acute cholangitis, as well as the improvement of examination and surgical techniques, the localization diagnosis, treatment and therapeutic effect of the disease have made great progress. 3,4 There are various treatment methods for acute cholangitis caused by complex and extensive biliary tract and liver lesions of hepatic duct stones. 5,6 Currently, individualized treatment is advocated for the specific conditions of patients. 7 However, many patients still relapse after receiving what is considered to be a relatively ideal treatment. Recurrent acute cholangitis is often accompanied by repeated infection of the biliary system, forming calculi and stenosis, which brings challenges to the diagnosis and treatment of patients. A study suggested that common bile duct corrosion after endoscopic cholecystectomy leads to recurrent choledocholithiasis and acute cholangitis. 8 A prospective study of 210 patients with acute cholangitis due to choledocholithiasis suggests that cholecystectomy does not prevent recurrence of acute cholangitis in Asian patients, and that early endoscopic papillectomy reduces the frequency of recurrence in these patients. 9 Ling et al investigated that biliary duodenal anastomosis is not an ideal method to reduce intrahepatic cholangitis nor is it the best choice to curb the recurrence of cholangitis. 10 The incidence of recurrent primary sclerosing cholangitis was found to be higher than before and was associated with increased morbidity and mortality. Patients with recurrent primary sclerosing cholangitis appear to have a more aggressive, immunoreactive phenotype. 11 It has been found that acute cholangitis, liver abscess, cirrhosis complications and CCA (cholangiocarcinoma) frequently occur in patients with recurrent pyogenic cholang -Abstract Truncated-
pharmacology & pharmacy,infectious diseases